CF Industries (CF) Q3 2025 10-Q Quarterly Report

Filed: Nov 6, 2025Period ending Sep 30, 2025
Health Care
Agricultural ChemicalsSEC EDGAR

CF Industries (CF) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

CF Industries Q3 2025 10-Q Analysis

Management Discussion & Analysis

  • No quarterly revenue or YoY change data disclosed in provided text
  • No profitability or margin figures reported in provided text
+3 more insights

Risk Factors

  • New project execution risk triggered by construction delays or cost overruns at Blue Point low-carbon ammonia facility
  • Increased capital expenditure risk as project funding needs at Blue Point may exceed current estimates
+3 more insights

CF Industries Q3 2025 Quarterly Financials
XBRL

Revenue

$1.7B

+21.1% YoY -12.2% QoQ

Net Income

$353M

+27.9% YoY -8.5% QoQ

Gross Margin

38.1%

+569bp YoY -185bp QoQ

Operating Margin

35.0%

+839bp YoY +68bp QoQ

Net Margin

21.3%

+113bp YoY +85bp QoQ

ROE

7.3%

Total Assets

$14.2B

EPS (Diluted)

$2.19

+41.3% YoY -6.8% QoQ

Operating Cash Flow

$1.1B

+14.3% YoY +89.0% QoQ

Source: XBRL data from CF Industries Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other CF Industries Quarterly Reports

Get deeper insights on CF Industries

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.